{
    "Trade/Device Name(s)": [
        "RAPIDPoint\u00ae 405 System Neonatal Bilirubin (nBili) Test",
        "RAPIDPoint\u00ae 405 System"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K110277",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073537"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "MQM"
    ],
    "Summary Letter Date": "July 11, 2011",
    "Summary Letter Received Date": "July 12, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1113"
    ],
    "Regulation Name(s)": [
        "Bilirubin in the Neonate Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Partial pressure of carbon dioxide",
        "Partial pressure of oxygen",
        "pH",
        "Sodium",
        "Potassium",
        "Ionized calcium",
        "Chloride",
        "Glucose",
        "Total hemoglobin",
        "Oxyhemoglobin",
        "Carboxyhemoglobin",
        "Sulfhemoglobin",
        "Neonatal bilirubin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RAPIDPoint\u00ae 405 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiple wavelength spectrophotometry (CO-oximetry)"
    ],
    "Methodologies": [
        "Spectrophotometry",
        "CO-oximetry"
    ],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens RAPIDPoint 405 System Neonatal Bilirubin (nBili) Test measuring bilirubin and other blood parameters in whole blood using spectrophotometry.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use in point of care or laboratory settings to measure neonatal bilirubin and other blood parameters in whole blood to aid in assessing risk of kernicterus and diagnosing related conditions.",
    "fda_folder": "Clinical Chemistry"
}